Lorraine Ludman1, Lewis Spitz. 1. Department of Pediatriz Surgery, Institute of Child Health, London, England.
Abstract
BACKGROUND/ PURPOSE: A small proportion of infants born with oesophageal atresia in which the gap between the 2 ends of the oesophagus is too great for an end-to-end anastomosis will require oesophageal replacement. Since 1981 the author's procedure of choice for oesophageal replacement has been gastric transposition. The long-term functional outcome appears to be satisfactory, but the quality of life of these patients has not been investigated formally. This report assesses the health-related quality of life (QOL) of 2 groups of patients born with oesophageal atresia who have undergone gastric transposition. METHODS: The study group comprised 28 patients aged 2 to 22 years who resided in England. Group 1 (n = 13), comprised patients who had undergone cervical oesophagostomy and gastrostomy without attempt at oesophageal anastomosis; group 2 (n = 15), comprised patients who had undergone previous attempts at reconstruction or replacement. QOL was assessed using modified versions of the Gastrointestinal Quality Of Life Index (GIQLI). RESULTS: QOL scores based on patients' responses showed no significant differences between the groups (124 v 119). However, the disease-specific symptom scores showed that patients in group 1 experienced fewer symptoms compared with those in group 2. Additionally, based on parental responses, patients in group 1 had higher QOL scores than those in group 2. QOL scores for patients aged 2 to 4 years (n = 5) did not differ between the groups (81 v 92, not significant). CONCLUSIONS: The quality of life for patients with oesophageal atresia undergoing gastric transposition was generally unimpaired by any side effects of gastric transposition. Patients undergoing gastric transposition as a primary procedure experienced fewer disease-specific symptoms in the medium term compared with patients who had undergone previous unsuccessful attempts at reconstruction or replacement of their oesophagus. Copyright 2003, Elsevier Science (USA). All rights reserved.
BACKGROUND/ PURPOSE: A small proportion of infants born with oesophageal atresia in which the gap between the 2 ends of the oesophagus is too great for an end-to-end anastomosis will require oesophageal replacement. Since 1981 the author's procedure of choice for oesophageal replacement has been gastric transposition. The long-term functional outcome appears to be satisfactory, but the quality of life of these patients has not been investigated formally. This report assesses the health-related quality of life (QOL) of 2 groups of patients born with oesophageal atresia who have undergone gastric transposition. METHODS: The study group comprised 28 patients aged 2 to 22 years who resided in England. Group 1 (n = 13), comprised patients who had undergone cervical oesophagostomy and gastrostomy without attempt at oesophageal anastomosis; group 2 (n = 15), comprised patients who had undergone previous attempts at reconstruction or replacement. QOL was assessed using modified versions of the Gastrointestinal Quality Of Life Index (GIQLI). RESULTS: QOL scores based on patients' responses showed no significant differences between the groups (124 v 119). However, the disease-specific symptom scores showed that patients in group 1 experienced fewer symptoms compared with those in group 2. Additionally, based on parental responses, patients in group 1 had higher QOL scores than those in group 2. QOL scores for patients aged 2 to 4 years (n = 5) did not differ between the groups (81 v 92, not significant). CONCLUSIONS: The quality of life for patients with oesophageal atresia undergoing gastric transposition was generally unimpaired by any side effects of gastric transposition. Patients undergoing gastric transposition as a primary procedure experienced fewer disease-specific symptoms in the medium term compared with patients who had undergone previous unsuccessful attempts at reconstruction or replacement of their oesophagus. Copyright 2003, Elsevier Science (USA). All rights reserved.
Authors: Antonio Dessanti; Vincenzo Di Benedetto; Marco Iannuccelli; Eraldo Sanna-Passino; Liliana Mura; Giuseppina Dessanti; Gian Mario Careddu; Maria Lucia Manunta; Paolo Cossu-Rocca; Ennio Sanna Journal: Pediatr Surg Int Date: 2005-08-23 Impact factor: 1.827
Authors: Giorgia Totonelli; Panagiotis Maghsoudlou; Jonathan M Fishman; Giuseppe Orlando; Tahera Ansari; Paul Sibbons; Martin A Birchall; Agostino Pierro; Simon Eaton; Paolo De Coppi Journal: World J Gastroenterol Date: 2012-12-21 Impact factor: 5.742
Authors: Michaela Dellenmark-Blom; John Eric Chaplin; Vladimir Gatzinsky; Linus Jönsson; Kate Abrahamson Journal: Qual Life Res Date: 2015-04-01 Impact factor: 4.147
Authors: Giorgia Totonelli; Panagiotis Maghsoudlou; Fanourious Georgiades; Massimo Garriboli; Kiron Koshy; Mark Turmaine; Michael Ashworth; Neil J Sebire; Agostino Pierro; Simon Eaton; Paolo De Coppi Journal: Pediatr Surg Int Date: 2013-01 Impact factor: 1.827
Authors: Catherine J Hunter; Mikael Petrosyan; Meghan E Connelly; Henri R Ford; Nam X Nguyen Journal: Pediatr Surg Int Date: 2009-12 Impact factor: 1.827